Skip to content

Clinical trials

Phase 2/3 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Japan Clear all

256 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20045
20054
20068
200713
200810
200914
201012
20118
201216
20138
20144
20159
20168
201715
201815
201912
202013
202112
202217
20239
20248
202522
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150
Recruiting44
Terminated29
Active, not recruiting23
Unknown status7
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Co., Ltd.12
Bristol-Myers Squibb11
Novartis Pharmaceuticals10
Pfizer10
AbbVie9
AstraZeneca8
Janssen Research & Development, LLC8
Takeda8
Boehringer Ingelheim7
Tanabe Pharma Corporation7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia10
Carcinoma, Non-Small-Cell Lung9
Colitis, Ulcerative8
Neoplasms7
Stomach Neoplasms7
Alzheimer Disease6
COVID-196
Crohn Disease6
Diabetes Mellitus, Type 26
Mental Disorders6

Trials

Showing 76 to 100 of 256. Each trial links to its page on Pharma Observatory.

156 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.